tradingkey.logo

SBC Medical Group Holdings Inc

SBC
4.410USD
+0.120+2.80%
Close 12/23, 16:00ETQuotes delayed by 15 min
452.36MMarket Cap
10.62P/E TTM

SBC Medical Group Holdings Inc

4.410
+0.120+2.80%

More Details of SBC Medical Group Holdings Inc Company

SBC Medical Group Holdings Incorporated is a management company, which owns, operates, and provides management services to cosmetic treatment centers. The Company is primarily focused on providing comprehensive management services to franchisee clinics, including, but not limited to, advertising and marketing needs across various platforms, staff management, booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumable's procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensure of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic’s customer rewards program, and payment tools for the franchisee clinics.

SBC Medical Group Holdings Inc Info

Ticker SymbolSBC
Company nameSBC Medical Group Holdings Inc
IPO dateSep 26, 2022
CEOAikawa (Yoshiyuki)
Number of employees863
Security typeOrdinary Share
Fiscal year-endSep 26
Address200 Spectrum Center Dr.
CityIRVINE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code92618
Phone19495930250
Websitehttps://ir.sbc-holdings.com/
Ticker SymbolSBC
IPO dateSep 26, 2022
CEOAikawa (Yoshiyuki)

Company Executives of SBC Medical Group Holdings Inc

Name
Name/Position
Position
Shareholding
Change
Dr. Yoshiyuki Aikawa
Dr. Yoshiyuki Aikawa
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
92.69M
-0.29%
Mr. Fumitoshi Fujiwara
Mr. Fumitoshi Fujiwara
Independent Director
Independent Director
--
--
Dr. Mike Sayama, Ph.D.
Dr. Mike Sayama, Ph.D.
Independent Director
Independent Director
--
--
Mr. Yuya Yoshida
Mr. Yuya Yoshida
Chief Financial Officer, Chief Operating Officer, Director
Chief Financial Officer, Chief Operating Officer, Director
--
--
Mr. Akira Komatsu
Mr. Akira Komatsu
Secretary
Secretary
--
--
Mr. Ken Edahiro
Mr. Ken Edahiro
Independent Director
Independent Director
--
--
Ms. Miki (Shimizu) Yamazaki
Ms. Miki (Shimizu) Yamazaki
Chief Strategy Officer
Chief Strategy Officer
--
--
Mr. Shinya Inoue
Mr. Shinya Inoue
Chief Marketing Officer
Chief Marketing Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Dr. Yoshiyuki Aikawa
Dr. Yoshiyuki Aikawa
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
92.69M
-0.29%
Mr. Fumitoshi Fujiwara
Mr. Fumitoshi Fujiwara
Independent Director
Independent Director
--
--
Dr. Mike Sayama, Ph.D.
Dr. Mike Sayama, Ph.D.
Independent Director
Independent Director
--
--
Mr. Yuya Yoshida
Mr. Yuya Yoshida
Chief Financial Officer, Chief Operating Officer, Director
Chief Financial Officer, Chief Operating Officer, Director
--
--
Mr. Akira Komatsu
Mr. Akira Komatsu
Secretary
Secretary
--
--
Mr. Ken Edahiro
Mr. Ken Edahiro
Independent Director
Independent Director
--
--

Revenue Breakdown

Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q2
FY2023Q1
FY2022
By BusinessUSD
Name
Revenue
Proportion
Procurement services
15.76M
36.34%
Royalty income
10.01M
23.08%
Rental services
6.85M
15.80%
Others
5.60M
12.93%
Management services
5.14M
11.85%
By RegionUSD
Name
Revenue
Proportion
United States
43.36M
100.00%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Procurement services
15.76M
36.34%
Royalty income
10.01M
23.08%
Rental services
6.85M
15.80%
Others
5.60M
12.93%
Management services
5.14M
11.85%

Shareholding Stats

Updated: Mon, Dec 15
Updated: Mon, Dec 15
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Aikawa (Yoshiyuki)
90.36%
BlackRock Institutional Trust Company, N.A.
0.25%
Geode Capital Management, L.L.C.
0.19%
The Vanguard Group, Inc.
0.08%
Northern Trust Investments, Inc.
0.06%
Other
9.07%
Shareholders
Shareholders
Proportion
Aikawa (Yoshiyuki)
90.36%
BlackRock Institutional Trust Company, N.A.
0.25%
Geode Capital Management, L.L.C.
0.19%
The Vanguard Group, Inc.
0.08%
Northern Trust Investments, Inc.
0.06%
Other
9.07%
Shareholder Types
Shareholders
Proportion
Individual Investor
90.38%
Investment Advisor
0.37%
Investment Advisor/Hedge Fund
0.31%
Hedge Fund
0.06%
Research Firm
0.06%
Pension Fund
0.02%
Other
8.79%

Institutional Shareholding

Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
66
685.51K
0.66%
-1.68M
2025Q2
34
93.16M
90.71%
-2.02M
2025Q1
57
98.13M
95.25%
-8.18M
2024Q4
71
101.71M
98.73%
-10.62M
2024Q3
70
99.28M
98.47%
+81.04M
2024Q2
67
5.24M
34.21%
-13.07M
2024Q1
67
5.30M
99.27%
-13.00M
2023Q4
64
5.86M
104.46%
-7.75M
2023Q3
62
2.59M
38.48%
-11.08M
2023Q2
62
2.62M
39.00%
-10.91M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Aikawa (Yoshiyuki)
92.69M
89.23%
-270.00K
-0.29%
Apr 15, 2025
BlackRock Institutional Trust Company, N.A.
252.13K
0.24%
+252.13K
--
Jun 30, 2025
Geode Capital Management, L.L.C.
98.08K
0.09%
+92.84K
+1771.79%
Jun 30, 2025
The Vanguard Group, Inc.
35.08K
0.03%
+35.08K
--
Jun 30, 2025
Northern Trust Investments, Inc.
27.68K
0.03%
+27.68K
--
Jun 30, 2025
SBI Securities Co., Ltd.
54.18K
0.05%
+37.62K
+227.27%
Jun 30, 2025
State Street Investment Management (US)
20.20K
0.02%
+20.20K
--
Jun 30, 2025
BlackRock Investment Management, LLC
16.69K
0.02%
+16.69K
--
Jun 30, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Global X Russell 2000 ETF
0%
ProShares UltraPro Russell2000
0%
Franklin US Small Cap Multifactor Index ETF
0%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
SPAC and New Issue ETF
0%
iShares Russell 2000 Value ETF
0%
iShares Micro-Cap ETF
0%
Global X Russell 2000 ETF
Proportion0%
ProShares UltraPro Russell2000
Proportion0%
Franklin US Small Cap Multifactor Index ETF
Proportion0%
ProShares Hedge Replication ETF
Proportion0%
iShares Russell 2000 ETF
Proportion0%
Proshares Ultra Russell 2000
Proportion0%
SPAC and New Issue ETF
Proportion0%
iShares Russell 2000 Value ETF
Proportion0%
iShares Micro-Cap ETF
Proportion0%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Split

Date
Type
Ratio
No Data
Date
Type
Ratio
No Data

FAQs

Who are the top five shareholders of SBC Medical Group Holdings Inc?

The top five shareholders of SBC Medical Group Holdings Inc are:
Aikawa (Yoshiyuki) holds 92.69M shares, accounting for 89.23% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 252.13K shares, accounting for 0.24% of the total shares.
Geode Capital Management, L.L.C. holds 98.08K shares, accounting for 0.09% of the total shares.
The Vanguard Group, Inc. holds 35.08K shares, accounting for 0.03% of the total shares.
Northern Trust Investments, Inc. holds 27.68K shares, accounting for 0.03% of the total shares.

What are the top three shareholder types of SBC Medical Group Holdings Inc?

The top three shareholder types of SBC Medical Group Holdings Inc are:
Aikawa (Yoshiyuki)
BlackRock Institutional Trust Company, N.A.
Geode Capital Management, L.L.C.

How many institutions hold shares of SBC Medical Group Holdings Inc (SBC)?

As of 2025Q3, 66 institutions hold shares of SBC Medical Group Holdings Inc, with a combined market value of approximately 685.51K, accounting for 0.66% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -90.05%.

What is the biggest source of revenue for SBC Medical Group Holdings Inc?

In FY2025Q2, the Procurement services business generated the highest revenue for SBC Medical Group Holdings Inc, amounting to 15.76M and accounting for 36.34% of total revenue.
KeyAI